My recollection is there were patients in the breast cancer trial that also had glioblastoma and saw their glioblastoma positively impacted by Leronlimab. Primary brain tumors are actually quite rare; brain tumors more typically result from metastatic lesions elsewhere, often from the lung, breast, and melanoma.